Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLASH: Fezolinetant for Hot Flashes in Men with Prostate Cancer on ADT
NCT06972875Phase 2Recruiting
- Sponsor
- The University of Vermont
- Start
- Dec 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fezolinetant in hot flashes, sponsored by The University of Vermont. Started Dec 2025; status: recruiting.
02
Drugs
fezolinetant
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT06972875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06972875.